Efficacy and safety of mirogabalin treatment in patients with diabetic peripheral neuropathic pain: A systematic review and meta-analysis of randomised controlled trials.

Reem Abdullah AlyoubiAysha Abdulmalek AlshareefSaud Musaab AldughaitherAbeer Mahdi AljaroudiAlwaleed AlabdulwahedFaisal Muhammed AlduraibiAhmed T MasoudAhmed Abu-Zaid

Published in: International journal of clinical practice (2020)

Our systematic review and meta-analysis revealed that in patients with DPNP, mirogabalin treatment was superior to placebo and pregabalin in decreasing the ADPS over time. Besides, mirogabalin was largely safe and associated with some adverse events that could be managed conservatively.

Keyphrases

neuropathic pain
spinal cord
spinal cord injury
type diabetes
randomized controlled trial
clinical trial
single cell
wound healing
open label